Visit our Re-post guidelines
Photo: Drug-resistant Klebsiella growing in blood culture.
The CDC announced this week that millions in the US contract 'super germs' and 23,000 die each year, but isn't their outdated antibiotic-and germ-focused disease model entirely to blame for this growing nightmare?
A new report from the Centers of Disease Control and Prevention (CDC) warns about antibiotic overuse and the resultant rise of 'super-bugs,' establishing for the first time different 'threat levels' for each type of drug resistant bacteria.
Titled, Antibiotic resistance threats in the United States, 2013, the report states: "Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections."
The report acknowledged that, "[M]ost deaths related to antibiotic resistance happen in healthcare settings such as hospitals and nursing homes," and the estimates are based on "conservative assumptions and are likely minimum estimates."
The report also offers a new pathogen grading system reminiscent of homeland security's grading of terrorism threats, but instead of red, orange or yellow, the CDC is using "urgent," "serious" and "concerning."
These are the CDC's list of most highly concerning bacteria, prioritized according to 'threat level':
- Clostridium difficile
- Carbapenem-resistant Enterobacteriaceae (CRE)
- Drug-resistant Neisseria gonorrhoeae
- Multidrug-resistant Acinetobacte
- Drug-resistant Campylobacte
- Fluconazole-resistant Candida (a fungus
- Extended spectrum β-lactamase producing Enterobacteriaceae (ESBLs)
- Vancomycin-resistant Enterococcus (VRE)
- Multidrug-resistant Pseudomonas aeruginos
- Drug-resistant Non-typhoidal Salmonella
- Drug-resistant Salmonella Typhi
- Drug-resistant Shigella
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Drug-resistant Streptococcus pneumoniae
- Drug-resistant tuberculosis
- Vancomycin-resistant Staphylococcus aureus (VRSA)
- Erythromycin-resistant Group A Streptococcus
- Clindamycin-resistant Group B Streptococcus
The CDC's director, Dr. Thomas Frieden, who recently caused worldwide alarm by describing Carbapenem resistant Enterobacteriaceae CRE as 'nightmare bacteria,' said if the current trends continue, "the medicine cabinet may be empty for patients who need them in the coming months and years."
But isn't our reliance on the 'medicine cabinet' and not the kitchen cupboard or spice rack at the heart of the problem?
The medicine cabinet has been filled with conventional antibiotics far too long. These mostly monochemical compounds are far too simplistic vis-à-vis the relatively complex array of antimicrobial compounds found within natural anti-infective spices and plant extracts and which have been used since time immemorial. Bacteria, which have evolved complex mechanisms to survive chemical poisoning, easily gain the upper hand. Not only do these agents indiscriminately kill the beneficial flora that enable us to produce infection-fighting compounds (e.g. bacteriocins, betaglucans, etc.), but they actually make the 'bad' bacteria stronger and more resistant to treatment.
How do antibiotics drive this drug resistance? Even when a conventional antibiotic is successful at destroying 99.9% of a harmful bacterial colony, generating the immediate appearance of success, the treatment will often leave the surviving minority subpopulation (in this case, the .1%) of bacteria to produce genetically-mediated resistance factors, as well as biofilm, enabling it to survive and eventually grow back to harmful proportions. When the .1% grows back to levels where it is capable of causing symptoms and signs of infection, the original antibiotic is completely ineffective; to the contrary, it will actually kill off all competing beneficial bacteria, making the antibiotic-resistant bacteria thrive. This then requires the use of even more toxic chemical treatments to attempt to kill the new drug resistant colony, repeating the same cycle over again. At the end of this road is multi-drug resistant infection, whose pathogenicity is a direct result of the use of these conventional agents, and which therefore can not be controlled by them.
Do we then blame conventional pharmaceutically-driven medicine's impotence vis-à-vis these germs on the germs themselves, painting them as 'super powerful' vectors of death and destruction, or do we acknowledge the failure of the CDC's default approach, which is to favor the germ model of disease where the emphasis is on using 'life denying' antibiotics (literally, anti- + bios or "against life") to fight pathogenic 'invaders,' rather than building up the inner terrain of micoflora with 'life affirming' probiotics (literally, pro- + bios or "for life) and immune system supportive food compounds which form the basis of healthy immunity?
As the disease-mongering and concomitant fear-mongering is ratcheted up by national and global health organizations, it becomes clear how seamlessly the military and medical industrial establishments have merged in both their language and symbolism. Metaphors overlap. We wage wars with surgical precision in the 'war theater,' much like the operating theater, and we surveil, and preemptively strike microbial 'terrorists' with chemical weapons, feigning surprise when the collateral damage on innocence bystanders (our cells, our flora) far surpasses that of the so-called enemy, who is blamed nonetheless for our misguided medical theory and practice creating the monster of treatment-resistant infection.
At GreenMedInfo.com we index research directly from the National Library of Medicine indicating that indeed, drug- and multidrug- resistant pathogens can be shown through the scientific method to succumb to natural compounds, including foods and spices. This research demonstrates clearly that the alarming new biological threats announced by the CDC, and then reiterated globally through the mainstream media, can be countermanded through the use of plant medicines that the majority of the world still uses, and which can be obtained inexpensively, if not also sometimes grown in your backyard for free. But this very boon is also a curse, insofar as the hundreds of millions of dollars of capital needed to fund the necessary phase I, II and III clinical trials required for FDA drug approval will not flow into non-patentable substances which offer no return on investment. THIS is the #1 reason why the CDC, and the conventional medical establishment at large, will ignore the already widely available natural solutions literally growing beneath our feet, and which have been time-tested, multi-culturally, for thousands of years and by millions of folks who knew only plant medicine until very recently. They will look at the data we have indexed on GreenMedInfo.com and ignore and/or discredit it because it is 'preclinical,' and therefore will not pass through the political- and economically-motivated gauntlet of evidence-based medicine which claims absolute truth is only attainable through double-blind, randomized, placebo-controlled and preferably multi-centered human clinical trials (despite the fact that these can require billions of capital to fund). We reject this totalitarian "gold standard" or "golden rule," which exemplifies so clearly the aphorism: 'they who own the gold make the rules.'
We have created several pages of data dedicated to the topic of natural substances which inhibit and/or kill drug resistant pathogens. You can navigate to the node on our site "Infection: Antibiotic Resistant" by selecting menu item RESEARCH > Ailments > Index: I's > Infection: Antibiotic Resistance. This disease research page, one of 3017 on our site, describes 97 natural substances which have been demonstrated to have inhibitory and/or destructive effects on a wide range of tested drug- and multi-drug resistant pathogens. You can also go to individual pages on our site, such as the one dedicated entirely to MRSA research, with 49 studies shown to exhibit anti-MRSA activity.
Let's take just one of these substances, garlic, as an example. It is truly one of the most effect antimicrobial agents known to modern medical researchers, and has been shown to destroy a wide range of drug-resistant pathogens including, Pseudomonas aeruginosa,   MRSA,  Staphylococcus epidermidis and Klebsiella pneumonia, multi-drug resistant mycobacterium tuberculosis, multi-drug resistant Streptococcus mutans, and multi-drug resistant Candida species. For additional research on this remarkable kitchen spice and medicine, read "How Garlic Can Save Your Life."
Garlic is only one of thousands of known natural antimicrobial agents, and its established value in fighting infection speaks volumes to how the CDC is erroneously contextualizing the growing antibiotic-resistance problem. The CDC presently seems incapable of acknowledging the fundamental failure of their disease model, which flies in the face of the precautionary principle by invariably using immune compromising and/or destroying interventions to wage war against what it believes is the primary cause of disease: germs. The fundamental truth that our immune state is the primary determinant in determining our susceptibility to infection, is completely obscured. And one can not vaccinate away vitamin D deficiency, poor nutrition, or the constant highly pathogenic infectious challenges that exist in our environment, many of which are enhanced by the use of antibiotics in our livestock. True immunity comes from sunlight, clean water and air, good nutrition, and stress reduction. And when we do need a 'medicine' to support a failing or dysfunctional immune system, let it be our food, as Hippocrates espoused so long ago in timeless wisdom.
 Kusum Harjai, Ravi Kumar, Sukhvinder Singh. Garlic blocks quorum sensing and attenuates the virulence of Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2009 Sep 18. PMID:19878318
 Ponmurugan Karuppiah, Shyamkumar Rajaram. Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens. Asian Pac J Trop Biomed. 2012 Aug ;2(8):597-601. PMID: 23569978
 Thomas Bjarnsholt, PeterØstrup Jensen, Thomas B Rasmussen, Lars Christophersen, Henrik Calum, Morten Hentzer, Hans-Petter Hougen, Jørgen Rygaard, Claus Moser, Leo Eberl, Niels Høiby, Michael Givskov. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology. 2005 Dec;151(Pt 12):3873-80. PMID:16339933
 Shih-Ming Tsao, Wen-Hu Liu, Mei-Chin Yin. Two diallyl sulphides derived from garlic inhibit meticillin-resistant Staphylococcus aureus infection in diabetic mice. J Med Microbiol. 2007 Jun;56(Pt 6):803-8. PMID: 17510266
 R R Cutler, P Wilson. Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus. Br J Biomed Sci. 2004;61(2):71-4. PMID:15250668
 Abdul Hannan, Muhammad Ikram Ullah, Muhammad Usman, Shahid Hussain, Muhammad Absar, Khursheed Javed. Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and non-multi-drug resistant mycobacterium tuberculosis. Pak J Pharm Sci. 2011 Jan;24(1):81-5. PMID: 21190924
 M M Fani, J Kohanteb, M Dayaghi. Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans. J Indian Soc Pedod Prev Dent. 2007 Oct-Dec;25(4):164-8. PMID: 18007101
 B A Iwalokun, A Ogunledun, D O Ogbolu, S B Bamiro, J Jimi-Omojola. In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria. J Med Food. 2004;7(3):327-33. PMID: 15383227